- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06586918
Perfusion Index Parameter
May 12, 2026 updated by: Medtronic - MITG
Verification of a Perfusion Index Parameter in Adult Volunteers
To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.
Study Overview
Status
Completed
Conditions
Detailed Description
Perfusion index parameters measured with an Investigational Pulse Oximetry PCBA, paired with Market Released sensors, will be compared to perfusion levels measured by a FDA-cleared device equipped with a laser Doppler technology-based device for blood perfusion measurements.
Continuous Perfusion index measurements will be taken during the test sequence.
Study Type
Observational
Enrollment (Actual)
32
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80218
- Medtronic Clinical Physiology Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy Male or Female volunteers age ≥18 years, weighing greater than 40kgs.
Description
Inclusion Criteria:
- Subjects ≥18 years of age
- Subject is able to participate for the duration of the study
- Subject is willing to sign an informed consent
- Subject weighs >40kg
Exclusion Criteria:
- Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect the ability to test sensors
- Physiologic abnormalities that prevent proper application of pulse oximetry sensor
- Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes.
- Raynaud Syndrome
- Repeated systolic blood pressure > 140mmHg -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy Volunteers
Observational study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perfusion Index (PI) correlation to doppler measurement
Time Frame: 1 hour
|
To confirm correlation of Perfusion Index measured by the investigational pulse oximeter PCBA and Market Released sensors to the laser doppler measure of skin perfusion (LDSP) as determined by an overall instantaneous (lag(0)) Spearman rank correlation.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Randall M Clark, M.D., Medtronic Clinical Physiology Lab
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 4, 2024
Primary Completion (Actual)
September 13, 2024
Study Completion (Actual)
September 13, 2024
Study Registration Dates
First Submitted
September 4, 2024
First Submitted That Met QC Criteria
September 4, 2024
First Posted (Actual)
September 19, 2024
Study Record Updates
Last Update Posted (Actual)
May 15, 2026
Last Update Submitted That Met QC Criteria
May 12, 2026
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- MDT23025OM2VLP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perfusion; Complications
-
Shanglei LiuRecruitingPerfusion; ComplicationsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingPerfusion; ComplicationsChina
-
Nihon KohdenCompleted
-
Christie Medical Holdings, Inc.TerminatedPerfusion; ComplicationsUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Quest Medical ImagingCompleted
-
Nova Southeastern UniversityCompletedPerfusion; Complications | Fluid Retention TissueUnited States
-
St. Bortolo HospitalUnknownMechanical Ventilation Complication | Perfusion; ComplicationsItaly
-
Inonu UniversityNot yet recruitingPerfusion; Complications | Arterial Catheterization, Peripheral
-
Tanta UniversityUnknownMyopia | Perfusion; ComplicationsEgypt
-
Jessa HospitalCompletedPerfusion; ComplicationsBelgium